At Injex Clinics, weve been delivering high-quality cosmetic treatments
"As a convenient, once-daily oral pill that delivers meaningful weight loss, this is obesity care designed for the real world," Eli Lilly CEO David Ricks said

Study period 1/1/2017 to 7/1/2025 Study population: inclusion Patients with A GLP-1 prescription for at least 90 days At least five pounds of weight loss while on the GLP-1 A weight reading between 30 days prior through 3 days after starting the GLP-1 A weight reading within 30 days of stopping the GLP-1 At least one weight reading 1 to 24 months following end of the GLP-1 Study population: exclusion Thyroid conditions (ever): ICD-10-CM E03*or E05* Eating disorders (ever): ICD-10-CM F50* Pregnancy within a year before GLP-1 start through GLP-1 stop Censoring Other weight loss medication or restart of GLP-1 Amputation Bariatric surgery Pregnancy that started in period after GLP-1 was stopped Outcomes Percent of weight change relative to initial weight loss after end of GLP-1 treatment GLP-1 A medication with a simple generic of semaglutide, liraglutide, or tirzepatide

Read more information about such choices at: We may also use technologies that let us know whether you viewed certain content, whether you viewed our emails or other electronic communications, and whether the advertising we place on the Services and other websites or mobile applications is effective
Injection Site Reactions For subcutaneous formulations, mild injection site reactions including redness, itching, swelling, or bruising occur occasionally
If you are experiencing extreme nausea, please inform a doctor immediately and discontinue until the appointment